IL6 and ischemia: HSPA1A was shown to inhibit the production of proinflammatory factors (TNF-α and IL-6) and inhibit the activity of matrix metalloprotein kinases (MMPs) and iNOS in both in vitro and in vivo models of ischemia (Belenichev et al. 2023).